NO143970C - Analogifremgangsmaate til fremstilling av terapeutisk aktive 1-aryl-2-(1-imidazolyl)alkyl etere og tio-etere - Google Patents

Analogifremgangsmaate til fremstilling av terapeutisk aktive 1-aryl-2-(1-imidazolyl)alkyl etere og tio-etere

Info

Publication number
NO143970C
NO143970C NO761481A NO761481A NO143970C NO 143970 C NO143970 C NO 143970C NO 761481 A NO761481 A NO 761481A NO 761481 A NO761481 A NO 761481A NO 143970 C NO143970 C NO 143970C
Authority
NO
Norway
Prior art keywords
ethers
imidazolyl
tio
aryl
preparation
Prior art date
Application number
NO761481A
Other languages
English (en)
Norwegian (no)
Other versions
NO761481L (fr
NO143970B (no
Inventor
Geoffrey Edward Gymer
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO761481L publication Critical patent/NO761481L/no
Publication of NO143970B publication Critical patent/NO143970B/no
Publication of NO143970C publication Critical patent/NO143970C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO761481A 1975-04-30 1976-04-29 Analogifremgangsmaate til fremstilling av terapeutisk aktive 1-aryl-2-(1-imidazolyl)alkyl etere og tio-etere NO143970C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1792275A GB1475271A (en) 1975-04-30 1975-04-30 1-aryl-2-1-imidazolyl-alkyl ethers and thioethers and their use as antifungal agents

Publications (3)

Publication Number Publication Date
NO761481L NO761481L (fr) 1976-11-02
NO143970B NO143970B (no) 1981-02-09
NO143970C true NO143970C (no) 1981-05-20

Family

ID=10103597

Family Applications (1)

Application Number Title Priority Date Filing Date
NO761481A NO143970C (no) 1975-04-30 1976-04-29 Analogifremgangsmaate til fremstilling av terapeutisk aktive 1-aryl-2-(1-imidazolyl)alkyl etere og tio-etere

Country Status (35)

Country Link
US (1) US4062966A (fr)
JP (1) JPS51133266A (fr)
AR (1) AR212592A1 (fr)
AT (1) AT350551B (fr)
BE (1) BE841309A (fr)
BG (1) BG25517A3 (fr)
CA (1) CA1063123A (fr)
CH (1) CH605930A5 (fr)
CS (1) CS191302B2 (fr)
DD (1) DD124983A5 (fr)
DE (1) DE2619381C3 (fr)
DK (1) DK147682C (fr)
EG (1) EG12222A (fr)
ES (1) ES447525A1 (fr)
FI (1) FI64157C (fr)
FR (1) FR2309223A1 (fr)
GB (1) GB1475271A (fr)
GR (1) GR60383B (fr)
HK (1) HK61979A (fr)
HU (1) HU174210B (fr)
IE (1) IE43272B1 (fr)
IL (1) IL49406A (fr)
LU (1) LU74866A1 (fr)
MX (1) MX3240E (fr)
MY (1) MY8000109A (fr)
NL (1) NL162911C (fr)
NO (1) NO143970C (fr)
PH (1) PH12906A (fr)
PL (1) PL104365B1 (fr)
PT (1) PT65045B (fr)
RO (1) RO72609A (fr)
SE (1) SE418860B (fr)
SU (1) SU622405A3 (fr)
YU (1) YU40646B (fr)
ZA (1) ZA762036B (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1511390A (en) * 1975-12-04 1978-05-17 Pfizer Ltd Imidazolylalkyl sulphide antifungal agents
EP0001654B1 (fr) * 1977-10-13 1981-07-22 Siegfried Aktiengesellschaft Dérivés d'imidazolyléthylène-oxyalcoyloxy et leurs analogues thio, leurs procédés de préparation et compositions pharmaceutiques les contenant
IT1096361B (it) * 1978-05-18 1985-08-26 Recordati Chem Pharm Dibenzileteri sostituiti terapeuticamente attivi
US4272545A (en) * 1979-02-02 1981-06-09 Syntex (U.S.A.) Inc. Derivatives of thienyl- and furyl-substituted N-butyl and N-phenyl imidazoles
US4307105A (en) * 1979-07-05 1981-12-22 E. R. Squibb & Sons, Inc. Imidazolylethoxymethyl derivatives of thiazole
US4315023A (en) * 1979-09-06 1982-02-09 Westwood Pharmaceuticals, Inc. 1-Phenethylimidazole derivatives
US4248881A (en) * 1979-12-20 1981-02-03 E. R. Squibb & Sons, Inc. Imidazolylethoxymethyl derivatives of pyrazole
CA1155853A (fr) * 1980-06-06 1983-10-25 Joseph A. Martin Derives d'imidazole, et leur preparation
US4458079A (en) * 1980-08-08 1984-07-03 Bristol-Myers Company Sulfur-containing imidazoles
ES8504779A1 (es) * 1984-02-02 1985-05-01 Ferrer Int Procedimiento de obtencion de nuevos derivados de 1h-imidazol
US4766140A (en) * 1984-06-18 1988-08-23 Eli Lilly And Company Method of inhibiting aromatase
IT1200422B (it) * 1985-03-19 1989-01-18 Ripari Gero Ist Farm Biolog Composto con attivita' antimicrobia,sua preparazione e composizioni farmaceutiche che lo contengono
DE3932552A1 (de) * 1989-09-29 1991-04-11 Basf Ag Verfahren zur herstellung von 1-hydroxyimidazol
US5270032A (en) * 1990-10-04 1993-12-14 The Research Foundation Of State University Of New York Composition and method for the prevention and treatment of candidiasis
US5399552A (en) * 1991-10-17 1995-03-21 Merck & Co, Inc Antibiotic peptides bearing aminoalkylthioether moieties
US6545163B1 (en) * 1995-10-02 2003-04-08 Napp Technologies Process to prepare 1-aryl-2-(1-imidazolyl) alkyl ethers and thioethers
CN101519403B (zh) * 2009-04-08 2012-05-30 广东工业大学 一种合成噻康唑的方法
BRPI0904249B1 (pt) 2009-08-28 2018-03-06 Biolab Sanus Farmacêutica Ltda. Compostos éteres aralquil benzílicos, processo de preparação dos mesmos, uso dos referidos compostos, composição farmacêutica
US11185548B2 (en) 2016-12-23 2021-11-30 Helmholtz Zentrum Munchen—Deutsches Forschungszentrum Für Gesundheit Und Umwelt (Gmbh) Inhibitors of cytochrome P450 family 7 subfamily B member 1 (CYP7B1) for use in treating diseases
CN110537545A (zh) * 2019-09-12 2019-12-06 青岛农业大学 噻康唑在制备用于防治植物病原菌的杀菌剂中的应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3354173A (en) * 1964-04-16 1967-11-21 Janssen Pharmaceutica Nv Imidazole carboxylates
US3575999A (en) * 1968-08-19 1971-04-20 Janssen Pharmaceutica Nv Ketal derivatives of imidazole
SU557755A3 (ru) * 1968-08-19 1977-05-05 Янссен Фармасьютика Н.В. (Фирма) Способ получени производных имидазола
LU60908A1 (fr) * 1969-05-21 1970-07-16
US3658813A (en) * 1970-01-13 1972-04-25 Janssen Pharmaceutica Nv 1-(beta-aryl-beta-(r-oxy)-ethyl)-imidazoles
DE2059949C3 (de) * 1970-12-05 1979-12-13 Bayer Ag, 5090 Leverkusen Thienyl-fettsäurederivate, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
DE2359922A1 (de) * 1973-12-01 1975-06-05 Hoechst Ag (1-alkyl-5-nitro-imidazolyl-2-alkyl)- heteroaryl-verbindungen und verfahren zu ihrer herstellung
DE2362171A1 (de) * 1973-12-14 1975-06-26 Hoechst Ag (1-alkyl-5-nitro-imidazolyl-2-alkyl)heteroaryl-verbindungen und verfahren zu ihrer herstellung
US3991202A (en) * 1974-01-31 1976-11-09 Janssen Pharmaceutica N.V. Imidazolium salts

Also Published As

Publication number Publication date
FR2309223A1 (fr) 1976-11-26
IE43272B1 (en) 1981-01-28
AU1319976A (en) 1977-03-31
FI761200A (fr) 1976-10-31
PT65045B (en) 1977-09-13
HU174210B (hu) 1979-11-28
ZA762036B (en) 1977-04-27
DE2619381B2 (de) 1977-10-06
NL162911C (nl) 1980-07-15
CS191302B2 (en) 1979-06-29
DK147682C (da) 1985-07-15
ES447525A1 (es) 1977-07-01
MY8000109A (en) 1980-12-31
FI64157B (fi) 1983-06-30
FR2309223B1 (fr) 1978-08-25
SU622405A3 (ru) 1978-08-30
MX3240E (es) 1980-08-06
YU40646B (en) 1986-04-30
DK147682B (da) 1984-11-12
NO761481L (fr) 1976-11-02
GB1475271A (en) 1977-06-01
NL7604583A (nl) 1976-11-02
JPS51133266A (en) 1976-11-18
LU74866A1 (fr) 1977-12-02
DD124983A5 (fr) 1977-03-23
SE7604975L (sv) 1976-10-31
GR60383B (en) 1978-05-24
BG25517A3 (en) 1978-10-10
DK154776A (da) 1976-10-31
AT350551B (de) 1979-06-11
DE2619381C3 (de) 1980-10-16
CH605930A5 (fr) 1978-10-13
SE418860B (sv) 1981-06-29
AR212592A1 (es) 1978-08-15
ATA310276A (de) 1978-11-15
PT65045A (en) 1976-05-01
NL162911B (nl) 1980-02-15
US4062966A (en) 1977-12-13
NO143970B (no) 1981-02-09
YU100976A (en) 1982-06-30
PL104365B1 (pl) 1979-08-31
IL49406A (en) 1979-09-30
FI64157C (fi) 1983-10-10
RO72609A (fr) 1982-02-01
HK61979A (en) 1979-09-07
IE43272L (en) 1976-10-30
BE841309A (fr) 1976-10-29
CA1063123A (fr) 1979-09-25
DE2619381A1 (de) 1976-11-11
JPS5331872B2 (fr) 1978-09-05
EG12222A (en) 1978-09-30
PH12906A (en) 1979-10-04
IL49406A0 (en) 1976-06-30

Similar Documents

Publication Publication Date Title
NO143970C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 1-aryl-2-(1-imidazolyl)alkyl etere og tio-etere
NO147450C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinazolonderivater
NO145691C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme decapeptidamider
SE402699B (sv) Forfarande for framstellning av en brusande dipeptidsotningsmedelstablett
NO151461C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive imidazolidinderivater
NO145379C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n2-arylsulfonyl-l-argininamider.
NO151040C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-halogenpyrimid-2-oner
NO147953C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive antracyklinglukosider
NO143796C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme piperazinyliminorifamyciner
NO146095C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive kinazolin-derivater
NO146359C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive cyproheptadinderivater
NO147750C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive og optisk aktive 11-desoksy-16-aryloksy-omega-tetranorprostaglandiner
NO149311C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive propanolindolderivater
NO146022C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme benzofenonderivater
NO146571C (no) Analogifremgangsmaate ved fremstilling av anti-inflammatorisk aktive imidazoler
NO151285C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive di-o-n-alkyl-glycerolderivater
NO146356C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive alkanolaminderivater
NO148454C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolidin-dionderivater
NO145163C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive antitumorglykosider
NO151008C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive nitroforbindelser
NO146863C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive alkyltiofenoksyalkylaminer
NO142907C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme fenylalkylaminer
NO147028C (no) Analogifremgangsmaate for fremstilling av farmasoeytisk aktive 1-hydroksyoktahydrobenzo(c)kinoliner
NO144741C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiopyrano-pyrazoler
NO143903C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-fluorpyrimidin-4-on-derivater